Alexander B, Odake K, Lawlor D, Swanger M. Coagulation, hemostasis, and plasma expanders: a quarter century enigma. Fed Proc. 1875;34:1429–40.

Bellomo R, Bion J, Finfer S, Myburgh J, Perner A, Reinhart K, et al. Open letter to the Executive Director of the European Medicines Agency concerning the licensing of hydroxyethyl starch solutions for fluid resuscitation. Br J Anaesth. 2014;112:595–600.

Bilotta F, Giordano G, Caroletti F, Pugliese F. Hydroxyethyl starch: A half-century enigma. Acta Anaesthesiol Scand. 2018. [Epub ahead of print].

DGAI, 2018. Available at (accessed November 2018).

EMA, 2013a. Available at (accessed November 2018).

EMA, 2013b. Available at (accessed November 2018).

EMA, 2013c. Available at (accessed November 2018).

EMA, 2017. Available at (accessed November 2018).

EMA, 2018a. Available at (accessed November 2018).

EMA, 2018b. Available at (accessed November 2018).

EMA, 2018c. Available at (accessed November 2018).

EMA, 2018d. Available at (accessed November 2018).

Ertmer C, Zwißler B, Van Aken H, Christ M, Spöhr F, Schneider A, et al. Fluid therapy and outcome: a prospective observational study in 65 German intensive care units between 2010 and 2011. Ann Intensive Care. 2018;8:27.

FDA, 2013. Available at (accessed November 2018).

FDA, 2017. Available at (accessed November 2018).

Laake JH, Møller MH. Continued licensing of hydroxyethyl starch despite high-quality data documenting harm in vulnerable patient populations: A sad day for patient safety. Acta Anaesthesiol Scand. 2018. [Epub ahead of print].

Laake JH, Tønnessen TI, Chew MS, Lipcsey M, Hjelmqvist H, Wilkman E, et al. The SSAI fully supports the suspension of hydroxyethyl-starch solutions commissioned by the European Medicines Agency. Acta Anaesthesiol Scand. 2018;62:874–5.

Legendre C, Thervet E, Page B, Percheron A, Noël LH, Kreis H. Hydroxyethylstarch and osmotic-nephrosis-like lesions in kidney transplantation. Lancet. 1993;324:248–9.

Mutter TC, Ruth CA, Dart AB. Hydroxyethyl starch (HES) versus other fluid therapies: effects on kidney function. Cochrane Database Syst Rev. 2013; CD007594.

Myburgh JA, Finfer S, Bellomo R, Billot L, Cass A, Gattas D, et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med. 2012;15:1901–11.

Perner A, Haase N, Guttormsen A, Tenhunen J, Klemenzson G, Aneman A, et al. Hydroxyethyl Starch 130/0.42 versus Ringer's Acetate in Severe Sepsis. N Engl J Med. 2012;367:124–34.

Public Citizen, 2017a. Available at (accessed November 2018).

Public Citizen, 2017b. Available at (accessed November 2018).

Roberts I, Shakur H, Bellomo R, Bio J, Finfer S, Hunt B, et al. Hydroxyethyl starch solutions and patient harm. Lancet. 2018;391:736.

ScienceNordic, 2012. Available at (accessed November 2018).

Takala J, Hartog C, Reinhart K. Safety of modern starches used during surgery: misleading conclusions. Anesth Analg. 2013;117:527–8.

Van Der Linden P, James M, Mythen M, Weiskopf RB. Safety of modern starches used during surgery. Anesth Analg. 2013;116:35–48.

Wiedermann CJ. Reporting bias in trials of volume resuscitation with hydroxyethyl starch. Wien Klin Wochenschr. 2014;126:189–94.

Zarychanski R, Abou-Setta AM, Turgeon AF, Houston BL, McIntyre L, Marshall JC, et al. Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically ill patients requiring volume resuscitation: a systematic review and meta-analysis. JAMA. 2013;309:678–88.

Timeline homepage
Anmelden/Registrieren Maximieren Minimieren